# Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI

> **NCT06870370** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 60 (estimated)

## Conditions studied

- Traumatic Brain Injury (TBI) Patients
- Intracranial Pressure
- Intensive Care Unit
- Mortality

## Interventions

- **DRUG:** propranolol
- **DRUG:** normal saline IV

## Key facts

- **NCT ID:** NCT06870370
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-20
- **Primary completion:** 2025-09-20
- **Final completion:** 2025-09-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06870370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06870370, "Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06870370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*